Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

BACKGROUND:The treatment of people with diabetes with metformin can reduce cardiovascular disease (CVD) and may reduce the risk of cancer. However, it is unknown whether or not metformin can reduce the risk of these outcomes in people with elevated blood glucose levels below the threshold for diabet...

Full description

Bibliographic Details
Main Authors:	Griffin, SJ, Bethel, MA, Holman, RR, Khunti, K, Wareham, N, Brierley, G, Davies, M, Dymond, A, Eichenberger, R, Evans, P, Gray, A, Greaves, C, Harrington, K, Hitman, G, Irving, G, Lessels, S, Millward, A, Petrie, JR, Rutter, M, Sampson, M, Sattar, N, Sharp, S
Format:	Journal article
Language:	English
Published:	NIHR Journals Library 2018

Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Similar Items